查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1487688

大麻二酚 (CBD) 油市場 - 按來源（大麻、大麻）、產品類型（原味、混合）、產品類別（調味、原味）、應用（保健品、藥品）、配方、配銷通路、全球預測2024 - 2032

Cannabidiol (CBD) Oil Market - By Source (Hemp, Marijuana), Product Type (Original, Blended), Product Category (Flavoured, Unflavoured), Application (Nutraceuticals, Pharmaceuticals), Formulation, Distribution Channel, Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 225 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在專注於發現其潛在優勢的研發工作不斷增加的推動下，2024 年至 2032 年間，全球大麻二酚 (CBD) 油市場規模的複合年成長率將達到 18.6%。隨著科學研究不斷揭示 CBD 的治療特性，包括其減輕疼痛、減少焦慮和減輕各種醫療狀況症狀的潛力，消費者對 CBD 產品的興趣呈指數級成長。

例如，2024 年 2 月，科羅拉多大學博爾德分校的新研究表明，富含 CBD 的大麻產品可能比以 THC 為主的大麻產品更有效地減少焦慮，並且沒有潛在的副作用。這項研究發表在《大麻與大麻素研究》上，涉及 300 名參與者，是第一個探討合法大麻對焦慮症狀影響的隨機試驗。

此外，各地區的監管變化和大麻衍生產品日益合法化也有助於市場的擴張。隨著消費者尋求自然療法和傳統藥物的替代品，CBD油成為有前途的選擇。這種不斷成長的需求凸顯了向整體健康實踐的典範轉移，並推動了 CBD 產業的創新，推動其成長軌跡。

整個大麻二酚 (CBD) 油產業根據來源、產品類型、產品類別、應用、配方、配銷通路和地區進行分類。

大麻細分市場將在 2024 年至 2032 年間經歷突破性發展。隨著全球對大麻態度的轉變和合法化努力的進展， CBD 油的市場不斷擴大。消費者尋求治療各種疾病的自然療法，導致對 CBD 產品的需求不斷成長。此外，萃取技術和產品配方的進步增強了 CBD 油的吸引力，推動其在更廣泛的大麻產業中的市場成長。

從2024 年到2032 年，混合細分市場的大麻二酚(CBD) 油市場佔有率將實現顯著的複合年成長率。 ，滿足不同消費者的喜好和需求。無論是與精油結合以獲得芳香療法的功效，還是注入維生素和營養素以增加健康益處，混合 CBD 油產品都提供了全面的健康方法。這些混合物為消費者提供了方便且可客製化的解決方案，以解決從緩解壓力到皮膚護理等各種健康問題。隨著市場不斷創新和多元化，對混合 CBD 油產品的需求可能會成長，從而塑造產業成長前景。

歐洲大麻二酚 (CBD) 石油市場從 2024 年到 2032 年將呈現可觀的複合年成長率。歐洲消費者擴大尋求自然療法來解決各種健康問題，推動了對 CBD 油產品的需求。此外，健康和護膚行業正在接受 CBD 油，因為它具有所謂的好處，進一步推動了市場成長。隨著可近性的不斷提高和產品種類的廣泛（包括油、膠囊和外用藥），歐洲對 CBD 油的需求可能會繼續呈上升趨勢。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • CBD 不斷成長的醫療應用
      • 與傳統藥物相比，人們對 CBD 的偏好越來越高
      • CBD 產品核准的監管環境不斷變化
      • 零售店 CBD 產品的銷售增加
    • 產業陷阱與挑戰
      • 與 CBD 油相關的副作用
      • 市面上有假冒和合成產品
      • 監理不確定性
  • 成長潛力分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：市場估計與預測：按來源分類，2018 年 - 2032 年

  • 主要趨勢
  • 麻
  • 大麻

第 6 章：市場估計與預測：按產品類型，2018 年 - 2032 年

  • 主要趨勢
  • 原來的
  • 混合

第 7 章：市場估計與預測：按產品類別，2018 - 2032

  • 主要趨勢
  • 調味 CBD 油
  • 無味 CBD 油

第 8 章：市場估計與預測：按應用分類，2018 年 - 2032 年

  • 主要趨勢
  • 營養保健品
  • 藥品
    • 疼痛管理
    • 焦慮和抑鬱
    • 睡眠障礙
    • 皮膚護理
    • 神經系統疾病
    • 其他製藥應用

第 9 章：市場估計與預測：按配方分類，2018 年 - 2032 年

  • 主要趨勢
  • 藥丸和膠囊
  • 乳霜和走珠
  • 經皮貼劑
  • 滴
  • 其他配方

第 10 章：市場估計與預測：按配銷通路，2018 年 - 2032 年

  • 主要趨勢
  • 線上
  • 離線
    • 醫院藥房
    • 零售店

第 11 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 12 章：公司簡介

  • Aurora Cannabis Inc
  • Bluebird Botanicals
  • BIOTA Biosciences
  • CHARLOTTE'S WEB
  • Elixinol
  • Endoca
  • Evora Worldwide
  • Green Roads
  • Hempstrol
  • Health Horizons
  • Medical Mary, LLC
  • Medterra CBD
  • Neurogan
簡介目錄
Product Code: 8545

Global Cannabidiol (CBD) Oil Market Size will witness 18.6% CAGR between 2024 and 2032, driven by increasing research and development efforts focused on uncovering its potential benefits. As scientific studies continue to shed light on CBD's therapeutic properties, including its potential to alleviate pain, reduce anxiety, and mitigate symptoms of various medical conditions, consumer interest in CBD products is growing exponentially.

For instance, in February 2024, new research from CU Boulder suggested that cannabis products high in CBD may be more effective at reducing anxiety than those dominated by THC and without the potential side effects. Published in Cannabis and Cannabinoid Research, the study involving 300 participants was the first randomized trial to explore the impact of legally available cannabis on anxiety symptoms.

Moreover, regulatory changes and increasing legalization of cannabis-derived products in various regions contribute to the market's expansion. As consumers seek natural remedies and alternatives to traditional pharmaceuticals, CBD oil emerges as a promising option. This rising demand underscores a paradigm shift towards holistic wellness practices and fuels innovation in the CBD industry, propelling its growth trajectory.

The overall Cannabidiol (CBD) Oil Industry is classified based on the source, product type, product category, application, formulation, distribution channel, and region.

The marijuana segment will undergo groundbreaking development from 2024 to 2032. Derived from the cannabis plant, CBD oil has gained popularity for its potential therapeutic benefits without the psychoactive effects of THC, another compound found in marijuana. As attitudes towards marijuana shift and legalization efforts progress globally, the market for CBD oil expands. Consumers seek natural remedies for various ailments, contributing to the growing demand for CBD products. Additionally, advancements in extraction techniques and product formulations enhance the appeal of CBD oil, driving its market growth within the broader marijuana industry.

The cannabidiol (CBD) oil market share from the blended segment will register a noteworthy CAGR from 2024 to 2032. Blending CBD oil with other natural compounds or ingredients enhances its versatility and effectiveness, catering to diverse consumer preferences and needs. Whether combined with essential oils for aromatherapy benefits or infused with vitamins and nutrients for added health benefits, blended CBD oil products offer a holistic approach to wellness. These blends provide consumers with a convenient and customizable solution to address various health concerns, from stress relief to skin care. As the market continues to innovate and diversify, the demand for blended CBD oil products could grow, shaping the industry growth outlook.

Europe cannabidiol (CBD) oil market will showcase an appreciable CAGR from 2024 to 2032. As regulatory frameworks evolve and public perception towards cannabis-derived products shifts, the market for CBD oil expands rapidly. Consumers in Europe are increasingly seeking natural remedies for various health concerns, driving the demand for CBD oil products. Moreover, the wellness and skincare industries are embracing CBD oil for its purported benefits, further fueling market growth. With increasing accessibility and a wide range of product offerings, including oils, capsules, and topicals, the demand for CBD oil in Europe could continue its upward trajectory.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing medical applications of CBD
      • 3.2.1.2 Growing preference for CBD over conventional pharmaceuticals
      • 3.2.1.3 Changing regulatory landscape for approval of CBD products
      • 3.2.1.4 Increasing sales of CBD products in retail stores
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with CBD oil
      • 3.2.2.2 Counterfeit and synthetic products available in the market
      • 3.2.2.3 Regulatory uncertainties
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemp
  • 5.3 Marijuana

Chapter 6 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Original
  • 6.3 Blended

Chapter 7 Market Estimates and Forecast, By Product Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Flavoured CBD oil
  • 7.3 Unflavoured CBD oil

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Nutraceuticals
  • 8.3 Pharmaceuticals
    • 8.3.1 Pain management
    • 8.3.2 Anxiety and depression
    • 8.3.3 Sleep disorder
    • 8.3.4 Skin care
    • 8.3.5 Neurological disorders
    • 8.3.6 Other pharmaceutical applications

Chapter 9 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pills & capsules
  • 9.3 Creams & roll-ons
  • 9.4 Transdermal patches
  • 9.5 Drops
  • 9.6 Other formulations

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Online
  • 10.3 Offline
    • 10.3.1 Hospital pharmacy
    • 10.3.2 Retail stores

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Aurora Cannabis Inc
  • 12.2 Bluebird Botanicals
  • 12.3 BIOTA Biosciences
  • 12.4 CHARLOTTE'S WEB
  • 12.5 Elixinol
  • 12.6 Endoca
  • 12.7 Evora Worldwide
  • 12.8 Green Roads
  • 12.9 Hempstrol
  • 12.10 Health Horizons
  • 12.11 Medical Mary, LLC
  • 12.12 Medterra CBD
  • 12.13 Neurogan